Your browser doesn't support javascript.
loading
Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy.
Schnekenburger, Michael; Lorant, Anne; Gajulapalli, Sruthi Reddy; Rajora, Ridhika; Lee, Jin-Young; Mazumder, Aloran; Yang, Haeun; Christov, Christo; Kang, Hyoung Jin; Pirotte, Bernard; Diederich, Marc.
Afiliação
  • Schnekenburger M; Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg, Luxembourg.
  • Lorant A; Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg, Luxembourg.
  • Gajulapalli SR; Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Rajora R; Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Lee JY; Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Mazumder A; Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Yang H; Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Christov C; Faculté de Médecine, Université de Lorraine, Vandœuvre-lès-Nancy, France.
  • Kang HJ; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital, Seoul, Republic of Korea.
  • Pirotte B; Laboratory of Medicinal Chemistry, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium.
  • Diederich M; Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Cancer Commun (Lond) ; 44(8): 915-920, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38976323
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Sirtuína 1 / Sirtuína 2 Limite: Animals / Humans Idioma: En Revista: Cancer Commun (Lond) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Luxemburgo
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Sirtuína 1 / Sirtuína 2 Limite: Animals / Humans Idioma: En Revista: Cancer Commun (Lond) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Luxemburgo